dc.contributor.author | Adamson, Catherine S | |
dc.contributor.author | Chibale, Kelly | |
dc.contributor.author | Goss, Rebecca J M | |
dc.contributor.author | Jaspars, Marcel | |
dc.contributor.author | Newman, David J | |
dc.contributor.author | Dorrington, Rosemary A | |
dc.date.accessioned | 2021-02-16T16:04:01Z | |
dc.date.available | 2021-02-16T16:04:01Z | |
dc.date.issued | 2021-03-21 | |
dc.identifier | 187921163 | |
dc.identifier | 244416df-e24d-468b-85a5-bd615ab84df9 | |
dc.identifier | 33524090 | |
dc.identifier | 85102078050 | |
dc.identifier | 000635214300002 | |
dc.identifier | 000680831100001 | |
dc.identifier | 85113863453 | |
dc.identifier.citation | Adamson , C S , Chibale , K , Goss , R J M , Jaspars , M , Newman , D J & Dorrington , R A 2021 , ' Antiviral drug discovery : preparing for the next pandemic ' , Chemical Society Reviews , vol. 50 , no. 6 , pp. 3647-3655 . https://doi.org/10.1039/d0cs01118e , https://doi.org/10.1039/d1cs90064a | en |
dc.identifier.issn | 0306-0012 | |
dc.identifier.uri | https://hdl.handle.net/2164/15878 | |
dc.description | Acknowledgements The authors also gratefully acknowledge financial support from the South African Medical Research Council (MRC) with funds received from the South African National Department of Health and the UK Government's Newton Fund (R. A. D., RL. M. G., K. C.), the UK Engineering and Physical Sciences Research Council EQATA (R. J. M. G.), the UK Global Challenge Research Fund (R. J. M. G., R. A. D.), the University of Cape Town (K. C.) and the South African Research Chairs Initiative of the Department of Science and Innovation, administered through the South African National Research Foundation (NRF) to K. C. (UID: 64767) and R. A. D. (UID: 87583). C. S. A. acknowledges financial support for SARS-CoV-2/Covid-19 research from UKMRC (CVG-1725-2020) and UKRI-DHSC (MR/Vo28464/1). The authors acknowledge Bronwyn Tweedie of the Rhodes University Print Services Unit who provided the graphics for Fig. 1 and thank Gordon Cragg for his insightful comments and encouragement during the preparation of this manuscript. Erratum: Antiviral drug discovery: Preparing for the next pandemic (Chem. Soc. Rev.( 2021) 50 (3647–3655) DOI: 10.1039/D0CS01118E) | en |
dc.format.extent | 9 | |
dc.format.extent | 2363691 | |
dc.language.iso | eng | |
dc.relation.ispartof | Chemical Society Reviews | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Antiviral Agents/chemistry | en |
dc.subject | Biological Products/chemistry | en |
dc.subject | COVID-19/drug therapy | en |
dc.subject | Coronavirus Protease Inhibitors/chemistry | en |
dc.subject | Drug Discovery/methods | en |
dc.subject | Humans | en |
dc.subject | Molecular Docking Simulation | en |
dc.subject | Molecular Targeted Therapy/methods | en |
dc.subject | Nucleic Acid Synthesis Inhibitors/chemistry | en |
dc.subject | Pandemics/prevention & control | en |
dc.subject | RNA, Viral/antagonists & inhibitors | en |
dc.subject | SARS-CoV-2/chemistry | en |
dc.subject | Small Molecule Libraries/chemistry | en |
dc.subject | QD Chemistry | en |
dc.subject | General Chemistry | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | CVG-1725-2020 | en |
dc.subject | Other | en |
dc.subject | MR/Vo28464/1 | en |
dc.subject.lcc | QD | en |
dc.title | Antiviral drug discovery : preparing for the next pandemic | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.The Marine Biodiscovery Centre | en |
dc.contributor.institution | University of Aberdeen.Marine Alliance for Science and Technology for Scotland (MASTS) | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1039/d0cs01118e | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85102078050&partnerID=8YFLogxK | en |
dc.identifier.vol | 50 | en |
dc.identifier.iss | 6 | en |